In 2023, Eli Lilly and Co conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards. The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.
Metric (tonnes) | 2024 | 2023 | 2022 | 2021 - 2017 |
---|---|---|---|---|
Total Waste Generated | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Waste Recovered | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Hazardous Waste Generated | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Non-Hazardous Waste Disposed | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected waste data points. To access the complete dataset with full disclosures and structure, create a free account to purchase the full dataset.
In 2023, Eli Lilly and Co generated a total of 118,000 metric tonnes of waste.
Of this amount, 88.98% of Eli Lilly and Co's total waste generated was recovered through methods such as recycling, reuse, or composting, while 10.76% was disposed of through landfilling, incineration, or combustion.
In 2023, Eli Lilly and Co reported a total waste generation of 118,000 metric tonnes, of which 88.98% was recovered through recycling, reuse, or composting. This high recovery rate suggests that Eli Lilly and Co has implemented strong circular economy practices and actively prioritizes sustainable waste management.
Since 2020, Eli Lilly and Co's total waste generation decreased by 9.23%, including a further 4.07% drop in 2023, highlighting a consistent and deliberate reduction in waste production over time.
Over the same period, Eli Lilly and Co's waste recovery rate declined by 3.6%, with a further 1.4% drop in 2023, underscoring a weakening in waste diversion performance and a potential drift away from circular waste strategies.
Overall, while Eli Lilly and Co has successfully reduced its total waste generation, its waste recovery efforts have also declined. This pattern could suggest a shift in strategy away from circular treatment methods or a lag in recovery infrastructure development.
In 2023, Eli Lilly and Co generated a total of 118,000 metric tonnes of waste.
Of this amount, 16.1% of Eli Lilly and Co's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment. 83.9% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.
Since 2020, Eli Lilly and Co's total waste generation decreased by 9.23%, with an additional 4.07% decline in 2023, suggesting a consistent and deliberate effort to minimize waste generation at the source.
Over the same period, Eli Lilly and Co saw a long-term increase of 4.66% in hazardous waste share, but a 9.98% reduction in 2023, indicating a recent improvement that may reflect updated production inputs, enhanced treatment, or stricter controls.
Overall, while Eli Lilly and Co is generating less waste and has made recent gains in reducing hazardousness, the long-term increase in harmful materials still casts doubt on the sustainability of its waste stream.